The crystal structure of dipeptidyl peptidase IV(CD26) reveals its functional regulation and enzymatic mechanism

被引:279
作者
Engel, M
Hoffmann, T
Wagner, L
Wermann, M
Heiser, U
Kiefersauer, R
Huber, R
Bode, W
Demuth, HU
Brandstetter, H
机构
[1] Proteros Biostruct GmbH, D-82152 Martinsried, Germany
[2] Probiodrug AG, Biozentrum, D-06120 Halle An Der Saale, Germany
[3] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
关键词
serine protease; oxyanion hole; substrate channeling; drug design; diabetes mellitus;
D O I
10.1073/pnas.0230620100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The membrane-bound glycoprotein dipeptidyl peptidase IV (DP IV, CD26) is a unique multifunctional protein, acting as receptor, binding and proteolytic molecule. We have determined the sequence and 1.8 A crystal structure of native DP IV prepared from porcine kidney. The crystal structure reveals a 2-2-2 symmetric tetrameric assembly which depends on the natively glycosylated beta-propeller blade IV. The crystal structure indicates that tetramerization of DP IV is a key mechanism to regulate its interaction with other components. Each subunit comprises two structural domains, the N-terminal eight-bladed beta-propeller with open Velcro topology and the C-terminal alpha/beta-hydrolase domain. Analogy with the structurally related POP and tricorn protease suggests that substrates access the buried active site through the p-propeller tunnel while products leave the active site through a separate side exit. A dipeptide mimicking inhibitor complexed to the active site discloses key determinants for substrate recognition, including a Glu-Glu motif that distinguishes DIP IV as an aminopeptidase and an oxyanion trap that binds and activates the P-2-carbonyl oxygen necessary for efficient postproline cleavage. We discuss active and nonactive site-directed inhibition strategies of this pharmaceutical target protein.
引用
收藏
页码:5063 / 5068
页数:6
相关论文
共 58 条
[1]   Two highly conserved glutamic acid residues in the predicted β propeller domain of dipeptidyl peptidase IV are required for its enzyme activity [J].
Abbott, CA ;
McCaughan, GW ;
Gorrell, MD .
FEBS LETTERS, 1999, 458 (03) :278-284
[2]   Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain [J].
Abbott, CA ;
McCaughan, GW ;
Levy, MT ;
Church, WB ;
Gorrell, MD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (03) :798-810
[3]   Truncated dipeptidyl peptidase IV is a potent anti-adhesion and anti-metastasis peptide for rat breast cancer cells [J].
Abdel-Ghany, M ;
Cheng, HC ;
Levine, RA ;
Pauli, BU .
INVASION & METASTASIS, 1998, 18 (01) :35-43
[4]   Methods used in the structure determination of bovine mitochondrial F-1 ATPase [J].
Abrahams, JP ;
Leslie, AGW .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 :30-42
[5]  
[Anonymous], 1992, THESIS TU MUNCHEN MU
[6]   2-cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV [J].
Ashworth, DM ;
Atrash, B ;
Baker, GR ;
Baxter, AJ ;
Jenkins, PD ;
Jones, DM ;
Szelke, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (10) :1163-1166
[7]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[8]   Structural basis for the processive protein degradation by tricorn protease [J].
Brandstetter, H ;
Kim, JS ;
Groll, M ;
Göttig, P ;
Huber, R .
BIOLOGICAL CHEMISTRY, 2002, 383 (7-8) :1157-1165
[9]   Crystal structure of the tricorn protease reveals a protein disassembly line [J].
Brandstetter, H ;
Kim, JS ;
Groll, M ;
Huber, R .
NATURE, 2001, 414 (6862) :466-470
[10]  
BROMME D, 1994, METHOD ENZYMOL, V244, P671